Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Earnings Preview: What to Expect From Gilead Sciences’ Report

Gilead Sciences, Inc. (GILD), based in Foster City, California, has a market capitalization of approximately $187.4 billion. The biopharmaceutical company discovers, develops, and delivers innovative medicines for serious diseases, with research focused on virology, oncology, and inflammation.

GILD is set to report its Q3 earnings soon. Ahead of the release, analysts expect the company to report diluted EPS of $2.16, down 12.6% from $2.47 in the year-ago quarter. However, GILD has exceeded Wall Street’s EPS estimates in each of the past four quarters, highlighting its consistent earnings performance.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.